• Prof(Dr) Shiba S Morris
• Neetu Rajpoot

The area of radioactive therapeutic substances, or radiopharmaceuticals, has expanded during the last several decades. Radioactive substances known as radioisotopes make up radiopharmaceuticals. Recently, radiopharmaceuticals have been employed for both diagnostic and therapeutic applications. Nuclear medicine uses more than 100 radioactive materials. Alpha particles, beta particles, and gamma radiations are the three categories of radioactive decays identified by the decay of radioactive substances. Alpha particles have a destructive impact and no ability to penetrate the skin since they are made up of two protons and two neutrons and have a huge mass and charge. Because beta particles are less massive and charged than alpha particles, they may enter tissues more easily and cause less damage. As a result, they can be utilised in treatment. Because gamma rays are massless and chargeless, they may enter deep organ tissue and be utilised for diagnostic imaging with a gamma camera. Thyroid gland cancer, hyperthyroidism, bone pain metastases, renal dysfunction, and myocardial and cerebral perfusion are among the conditions for which radiopharmaceuticals were developed for both diagnostic and therapeutic purposes. Additionally, thermo-labile materials including syringes, catheters, vitamins, hormones, and surgical dressings can be sterilised using the radioactive material. Nuclear medicine offers a number of benefits, including high treatment efficacy, safe diagnosis, no radiation buildup, and tumour localisation. The goal of the nuclear pharmacy division nowadays is to develop novel radioactive pharmaceutical substances that will be crucial and successful in the treatment of cancer. The development of radiopharmaceuticals is crucial to the treatment of millions of tumour patients worldwide.  

Keywords: Radiopharmaceuticals, Thyroid gland, Bone pain, Diagnosis, Therapeutic effect,

"Radiopharmaceuticals Its Preparation, Radioactivity, and Applications Review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 10, page no.g141-g155, October-2024, Available :http://www.jetir.org/papers/JETIR2410619.pdf

"Radiopharmaceuticals Its Preparation, Radioactivity, and Applications Review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 10, page no. ppg141-g155, October-2024, Available at : http://www.jetir.org/papers/JETIR2410619.pdf